Pharma Journalist - Page 124 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

FDA Accepts LEQEMBI BLA for Subcutaneous Dosing in Early Alzheimer’s Treatment

Daiichi Sankyo Acquires IP Rights for Anti-TA-MUC1 Antibody DS-3939 from Glycotope

Umoja Biopharma Secures $100M in Oversubscribed Series C to Advance CAR T Pipeline

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Variant Bio Partners with Novo Nordisk to Discover Metabolic Disease Targets

Tempest Receives Orphan Drug Designation for Amezalpat in HCC Treatment

Sentynl Announces FDA Acceptance and Priority Review of CUTX-101 for Menkes Disease

Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager